TSE
Trinseo PLC0.4834
-0.0667-12.1%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
17.40MP/E (TTM)
-Basic EPS (TTM)
-11.57Dividend Yield
0.05%Recent Filings
8-K
Q4 sales drop, restructuring hits
Trinseo reported Q4 2025 net sales of $663M, down 19% from prior year amid lower volumes across segments and pricing pressure. Net loss swelled to $251M due to $127M restructuring charges from closing Italian MMA production and German polystyrene assets, yet Adjusted EBITDA held flat at $26M on cost savings. Free cash flow turned positive at $7M. Ongoing creditor talks loom large.
10-K
FY2025 results
Trinseo's FY2025 delivered net sales of $2.97B, down 15% y/y from weaker volumes across segments and pricing pressure, yet Adjusted EBITDA held at $162.5M amid restructuring gains. Q4 saw MMA/ACH shutdowns in Italy and PS closure in Schkopau, Germany, targeting $30M annualized profitability uplift into 2026 while exiting cyclical assets. Engineered Materials bucked trends, lifting Adjusted EBITDA 14% to $117.3M on mix shifts, but Latex Binders and Polymer Solutions margins compressed. Liquidity stood at $334M year-end, with $2.59B debt; dividends suspended. NYSE delisting hit March 2026 on sub-$15M market cap. Debt covenant risks loom large.
8-K
NYSE delists Trinseo shares
Trinseo PLC received NYSE notice on March 2, 2026, to delist its shares after average market cap fell below $15 million over 30 trading days, triggering immediate trading suspension. This follows prior non-compliance with $50 million market cap, equity, and $1.00 share price standards. Delisting won't disrupt operations or SEC reporting. Trading may shift to OTC Pink, but liquidity remains uncertain.
8-K
Grace periods invoked on debt
Trinseo's subsidiaries amended their credit agreement on February 16, 2026, extending the interest payment grace period to March 19 for amounts due February 1 to March 1, aligning with the 2L Notes indenture. The next $10.0 million interest on 7.625% second lien notes due 2029, payable February 17, triggered a 30-day grace period election despite sufficient cash. Grace buys time for capital structure talks. Default looms if unpaid by deadline.
8-K
Board adds restructuring experts
Trinseo expanded its board to eleven members on January 16, 2026, appointing independent directors Carol Flaton and Jill Frizzley effective immediately. Flaton brings 30+ years in banking, restructuring, and governance; Frizzley offers expertise in corporate governance and transformations. These additions support ongoing capital structure talks with stakeholders. New directors receive $50,000 monthly fees via amended consulting agreements. Board expertise bolsters restructuring efforts.
IPO
Website
Employees
Sector
Industry
AVNT
Avient Corporation
30.50+0.02
BGLC
BioNexus Gene Lab Corp
4.12-0.02
CC
Chemours Company (The)
11.69-0.09
CE
Celanese Corporation
40.95-1.54
DD
DuPont de Nemours, Inc.
40.45-0.16
EMN
Eastman Chemical Company
63.65-0.30
LYB
LyondellBasell Industries NV
42.98-0.36
SINC
Sincerity Applied Materials Hol
7.86-0.04
SYHMY
Synthomer PLC
0.70+0.00
WLK
Westlake Corporation
73.34-0.29